USCDI Export for the Public
| Classification Level Sort descending | Data Class | Data Class Description | Data Element | Data Element Description | Applicable Standards | Submitter Name | Submitter Organization | Submission Date |
|---|---|---|---|---|---|---|---|---|
| Level 0 | Medical Devices | Instrument, machine, appliance, implant, software, or similar device intended to be used for a medical purpose. |
Ventilator measured plateau pressure | The measured plateau pressure on the ventilator if the patient is receiving mechanical ventilation |
Airway type LOINC LL5542-7 |
Ali Abbasi MD- on behalf of the I-SPY COVID investigators | I-SPY COVID Trial Investigators | |
| Level 0 | Medical Devices | Instrument, machine, appliance, implant, software, or similar device intended to be used for a medical purpose. |
Ventilator Mode | The mode of mechanical ventilation if the patient is receiving mechanical ventilation. Could refer to LOINV 20124-4 for options. |
Airway type LOINC LL5542-7 |
Ali Abbasi MD- on behalf of the I-SPY COVID investigators | I-SPY COVID Trial Investigators | |
| Level 0 | Genomics | Molecular Consequence | Molecular consequence is a calculation of the effect of the sequence change if the allele is in a gene (source: NCBI, https://www.ncbi.nlm.nih.gov/clinvar/docs/details/). |
The Sequence Ontology is a collaborative ontology project for the definition of sequence features used in biological sequence annotation. |
May Terry | MITRE Corporation | ||
| Level 0 | Provenance | The metadata, or extra information about data, regarding who created the data and when it was created. |
Case Report Version Number | An integer value used to version successive replacement documents of an electronic case report. |
Sarah Gaunt | The Association of Public Health Laboratories (APHL) | ||
| Level 0 | Clinical Notes | Narrative patient data relevant to the context identified by note types.
|
Colonoscopy | Narrative clinical assessment of the Colonoscopy results. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
| Level 0 | Medical Devices | Instrument, machine, appliance, implant, software, or similar device intended to be used for a medical purpose. |
Medical Device Name | The name of the medical device. |
Sandi Mitchell | J P Systems, Inc. | ||
| Level 0 | Medications | Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease. |
Cannabinoids | As the use of medical cannabis, OTC cannabidiol (CBD), and adult use cannabis (medical marijuana), and recreational cannabis is more frequent - there is the potential for drug-drug interactions; and awareness for peri-operative elective or urgent surgical procedures and/or hospitalizations. It is not just the added sedation - and perhaps safer than opioids - but the emphasis here is that cannabinoids have the real potential to affect the metabolism of OTHER medications especially those that have a narrow therapeutic index or other medications that have high-protein binding. A standardized format will provide the foundation for drug-drug interaction screening - vs. a multitude of inconsistent entries. Although medical cannabis is technically DEA class-1; there is high probability that medical cannabis may be transitioned to DEA class-3 in the very near future (see recent CSR memo added to the 'Use Case' tab). Additionally, this idea is also for cannabidiol (CBD) which is over the counter (OTC) - so not just limited to prescription Epidiolex. Additionally, medical cannabis preparations often have unique dosage forms (e.g., badder, butter). |
Paul T. Kocis, PharmD, MPH | Dept of Pharmacology, Penn State College of Medicine | ||
| Level 0 | Problems | Condition, diagnosis, or reason for seeking medical attention. |
Date of First Noted/Documented | Date of first noted/documented by a qualified professional of the presence of a problem or condition affecting a patient. |
Standard Date/Time formats |
Tayler Williams | American Medical Informatics Association (AMIA) | |
| Level 0 | Adverse Events | Unintended effects associated with clinical interventions. |
Recorder | Who recorded the adverse event | HL7.org FHIR R4 v4.0 |
Sandi Mitchell | J P Systems, Inc. | |
| Level 0 | Clinical Tests | Non-imaging and non-laboratory tests performed that result in structured or unstructured findings specific to the patient to facilitate the diagnosis and management of conditions. |
EKG/ECG Tracing Image | Narrative interpretation of the EKG/ECG Tracing Image. |
Please see suggestions from attached Excel document |
Melissa Ayres | SSA | |
| Level 0 | Health Status Assessments | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s authorized representative, or patient’s healthcare provider that could identify a need, problem, or condition. |
Pain Assessment | An assessment of a person’s pain, which could include assessment of acute and chronic pain using standardized assessment tools. Assessments of pain include but not limited to pain severity, interference of pain on activity, and pain impact on mood or sleep using unidimensional or multidimensional assessment tools. | LOINC and SNOMED CT |
|||
| Level 0 | Health Status Assessments | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s authorized representative, or patient’s healthcare provider that could identify a need, problem, or condition. |
Depression Screening | Assessment of clinical depression using standardized tools. |
LOINC |
Grace Glennon, on behalf of NCQA | NCQA | |
| Level 0 | Patient Demographics/Information | Data used to categorize individuals for identification, records matching, and other purposes. |
HL7-Identifier | Globally unique identifier assigned to a patient by an organization asserting compliance with the referenced HL7 FHIR Identify Matching IG |
A system exists for using the identifier within HL7 FHIR transactions, particularly those invoking $match, but the standard also intends for the identifier to be used in other health information exchange transaction types as well as in non-healthcare specific transactions for example in OpenID Connect identity claims. |
Julie Maas | EMR Direct | |
| Level 0 | Health Status Assessments | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s authorized representative, or patient’s healthcare provider that could identify a need, problem, or condition. |
Mental Health Status | Assessment of or screening for the presence of a mental or behavioral health condition. |
Various specific mental health status measures exist in LOINC, including the PHQ-9 for depression, the GAD-7 for anxiety, and the C-SSRS for suicide risk. |
Michael Schoenbaum | National Institute of Mental Health | |
| Level 0 | Health Status Assessments | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s authorized representative, or patient’s healthcare provider that could identify a need, problem, or condition. |
Care Team Member Completing Health Status Assessment | Care Team Member Conducting Health Status Assessment |
For the Care Team Member Identifier: National Provider Identifier (NPI) and National Council of State Boards of Nursing Identifier (NCSBN ID). |
Tayler Williams | American Medical Informatics Association (AMIA) | |
| Level 0 | Laboratory | Analysis of clinical specimens to obtain information about the health of a patient. |
Test Result Harmonization Status | Harmonization status indicates equivalency of results across platforms and vendors, ie, a harmonized test for a particular analyte and specimen yield results equivalent to other harmonized tests for that analyte and specimen. Harmonization is required for full clinical interoperability of test results. Results from harmonized tests may be interpreted and trended together, and may use the same calculation and decision support rules. Machine learning models may be trained and applied to data sets from different test platforms and vendors if the tests are harmonized. Tests that are not harmonized do not yield comparable results and should be interpreted and processed separately, not in aggregate with other tests. Incorrect assumption of harmonization status is a serious patient safety risk, and lack of harmonization information impedes public health interpretation of test results. |
These proposed elements are a work in progress and the CAP urges that the vocabulary standards listed be considered for a future version of USCDI: Reference Range: Name and Address of Laboratory Location: Condition & Disposition of Specimens: Test Result Harmonization Status: |
Han Tran | College of American Pathologists (CAP) | |
| Level 0 | Work Information | Occupational Exposure/Hazard | A hazard that is specific to a person's work or work environment for a single job and with which the person might come in contact. A hazard is a source of potential harm to an individual's physical or mental health (e.g., biological, chemical, physical, psychological, radiological). |
LOINC History of Occupational hazard | 87729-0 |
Sarah Gaunt | The Association of Public Health Laboratories (APHL) | ||
| Level 0 | Medical Devices | Instrument, machine, appliance, implant, software, or similar device intended to be used for a medical purpose. |
Ventilator set positive end expiratory pressure | The set positive end expiratory pressure (PEEP) if the patient is receiving mechanical ventilation or a biphasic positive airway pressure. |
Airway type LOINC LL5542-7 |
Ali Abbasi MD- on behalf of the I-SPY COVID investigators | I-SPY COVID Trial Investigators | |
| Level 0 | Adverse Events | Unintended effects associated with clinical interventions. |
Location | Location where adverse event occurred | HL7.org FHIR R4 v4.0 |
Sandi Mitchell | J P Systems, Inc. | |
| Level 0 | Pregnancy Information | Gestational Age Determination Method | Method for estimating gestational age, e.g., ultrasound, date of LMP. |
Value Set: Estimated Date of Delivery Including Method (https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.11.20.9.81/expansion) |
Sarah Gaunt | The Association of Public Health Laboratories (APHL) |
